GO
| HSI1 | 25,511.10 | 0.00 | -- |
| HSCEI1 | 8,445.37 | 0.00 | -- |
| Back Zoom + Zoom - Block Traded | |
|
2026-08-25 18:03:44 WUXI BIO (02269.HK) announced its interim results for the six months ended June 2026. Revenue lifted 18.4% YoY to RMB11.787 billion. Net profit gained 4.3% YoY to RMB2.44 billion, with EPS at RMB0.6. Adjusted net profit climbed 38.4% to RMB3.306 billion, while adjusted net profit margin improved from 24% to 28%. No dividend was declared. ~ AASTOCKS Financial News Website: www.aastocks.com | |